Cite

    Paul Emery et al.. “074 Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis.” Rheumatology, vol. 58, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100094055577.0x00001c